What companies are ABVX's competitors?

Abivax S.A. (ABVX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does ABVX compare to its peers?

The peer comparison table on this page shows Abivax S.A. (ABVX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does ABVX operate in?

Abivax S.A. (ABVX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

ABVX

Abivax S.A.

NASDAQ·Biotechnology · Healthcare

$118.95$4.16+3.62%

Pre-market·$118.12−0.70%

Market cap$8.73B·Market closed·Sep 8 8:00 PM UTC

Frequently Asked Questions About ABVX

What companies are ABVX's competitors?: Abivax S.A. (ABVX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ABVX compare to its peers?: The peer comparison table on this page shows Abivax S.A. (ABVX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ABVX operate in?: Abivax S.A. (ABVX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

ABVX

Abivax S.A.

NASDAQ·Biotechnology · Healthcare

$118.95$4.16+3.62%

Pre-market·$118.12−0.70%

Market cap$8.73B·Market closed·Sep 8 8:00 PM UTC

Peers


JAZZ	Jazz Pharmaceuticals plc	$240.07	$15.1B
HALO	Halozyme Therapeutics, Inc.	$108.31	$12.8B
MDGL	Madrigal Pharmaceuticals, Inc.	$534.16	$12.3B
CORT	Corcept Therapeutics Incorporated	$113.98	$12.3B
AXSM	Axsome Therapeutics, Inc.	$207.82	$10.7B
CYTK	Cytokinetics, Incorporated	$75.35	$9.4B
NUVL	Nuvalent, Inc.	$123.96	$9.1B
MTSR	Metsera, Inc.	$70.50	$7.4B
RYTM	Rhythm Pharmaceuticals, Inc.	$101.80	$7.0B
MRUS	Merus N.V.	$90.00	$6.8B

Frequently Asked Questions About ABVX

What companies are ABVX's competitors?: Abivax S.A. (ABVX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ABVX compare to its peers?: The peer comparison table on this page shows Abivax S.A. (ABVX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ABVX operate in?: Abivax S.A. (ABVX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.